C9 - Research Ethics & Integrity
University Compliance Owner: Professor Anton Middelberg,ÌýDeputy Vice Chancellor & Vice President (Research)
| Tier | Act/Code | Purpose | DSO* |
|---|---|---|---|
| 3 | An Act for the promotion of animal welfare; and for other purposes. |
Dr Adam O'Connell Dr Monica Kerr |
|
| 3 |
An Act to regulate the use of reproductive technology and research involving experimentation with human reproductive material. |
Dr Monica Kerr Director, Ethics, Compliance & Integrity |
|
| 3 |
The Code encompasses all aspects of the care and use of animals for scientific purposes where the aim is to acquire, develop or demonstrate knowledge or techniques in any area of science—for example, medicine, biology, agriculture, veterinary and other animal sciences, industry and teaching. Compliance with the Code is a prerequisite for receipt of NHMRC funding. From 1 January 2014, the NHMRC Funding Agreement will reflect the need for compliance with the 8th edition of the Code. |
Dr Adam O'Connell Dr Monica Kerr |
|
| 1 | Ìý |
The 2018 Code articulates broad principles and responsibilities that provide a framework for responsible research conduct in Australia and has broad relevance across all research disciplines. Compliance with the Code is a prerequisite for the receipt of public grant funding, including from the National Health and Medical Research Council (NHMRC), and the Australian Research Council (ARC). |
Dr Monica Kerr Acting Manager, Research Ethics, Compliance and Integrity |
| 1 | An Act to establish an Australian Research Council and to provide for the funding of research programs, and for related purposes |
Dr Michael Millan Executive Director Research Services |
|
| 3 | An Act relating to diseases and pests that may cause harm to human, animal or plant health or the environment. | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to establish a Civil Aviation Safety Authority with functions relating to civil aviation, in particular the safety of civil aviation, and for related purposes | URAF | |
| 3 | Part 101 sets out the requirements for the operation of unmanned aircraft | URAF | |
| 3 | Regulation 13E controls the conditions for exportation from Australia of goods specified in the . | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | This Act establishes a data sharing scheme under which Commonwealth bodies are authorised to share their public sector data with accredited users, and accredited users are authorised to collect and use the data, in a controlled way. |
Professor Bruce NorthcoteÌý Manager, Digital Stewardship |
|
| 1 | An Act to regulate dealings in certain goods, services and technologies, and for related purposes. |
Professor Bruce NorthcoteÌý Ms Debra Hassen |
|
| 2 |
An Act to provide a legal framework to protect and manage nationally and internationally important flora, fauna, ecological communities and heritage places, defined in the Act, as matters of national environmental significance. The Act is the Australian Government's central piece of environmental legislation. TheÌýÌýfacilitate access to, and regulate the use of, native genetic and biochemical resources. |
Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 |
An Act to establish a scheme to improve the transparency of activities undertaken on behalf of foreign principals, and for other purposes. The following Rules are made under the Act and give detail about the operation of the Scheme: |
Professor Bruce Northcote Chief Security Officer |
|
| 3 | An Act to regulate activities involving gene technology; and for other purposes.ÌýThe object of this Act is to protect the health and safety of people, and to protect the environment, by identifying risks posed by or as a result of gene technology, and by managing those risks through regulating certain dealings with GMOs. | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to regulate activities involving gene technology, and for related purposes. The object of this Act is to protect the health and safety of people, and to protect the environment, by identifying risks posed by or as a result of gene technology, and by managing those risks through regulating certain dealings with GMOs. | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to impose charges on licences issued under the Gene Technology Act 2000, and for related purposes | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to provide for the designation of areas of the State for the purposes of preserving for marketing purposes the identity of certain food crops according to whether they are genetically modified crops or non-genetically modified crops; to provide for the segregation of genetically modified food crops and their products in appropriate cases; to provide for associated regulatory powers; to provide certain protections with respect to the spread of genetically modified plant material; and for other purposes.Ìý | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to regulate matters relating to livestock and for other purposes. | Dr Adam O'Connell Animal Welfare Officer |
|
| 3 |
An Act to establish a National Health and Medical Research Council, and for related purposes. |
Dr Monica Kerr Dr Michael Millan Executive Director Research Services |
|
| 3 | An Act to comprehensively reform key offences dealing with threats to national security, particularly those posed by foreign principals. | Professor Bruce Northcote Chief Security Officer |
|
| 1 |
The National Statement (2007) consists of a series of Guidelines made in accordance with the National Health and Medical Research Council Act 1992. Compliance with the National Statement is a prerequisite for receipt of National Health and Medical Research Council funding. |
Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to provide for the protection of plants from pests, the regulation of the movement of plants into, within and out of the State, and the control, destruction and suppression of pests and for other purposes. | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to prohibit human cloning and other unacceptable practices associated with reproductive technology and for other purposes. | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to prohibit human cloning for reproduction and other unacceptable practices associated with reproductive technology, and for related purposes. The object of this Act is to address concerns, including ethical concerns, about scientific developments in relation to human reproduction and the utilisation of human embryos by prohibiting certain practices. | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to regulate certain activities involving the use of human embryos, and for related purposes. The object of this Act is to address concerns, including ethical concerns, about scientific developments in relation to human reproduction and the utilisation of human embryos by regulating activities that involve the use of certain human embryos created by assisted reproductive technology or by other means. | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 3 | An Act to regulate certain activities involving the use of human embryos and other related activities; to amend the Reproductive Technology Act 1988; and for other purposes. | Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
|
| 2 | This Act creates a framework for managing risks to national security relating to critical infrastructure. |
Professor Bruce Northcote |
|
| 2 | An Act to amend legislation relating to critical infrastructure, including by identifying theÌýhigher education and research sectorÌýas a critical infrastructure sector. | Professor Bruce Northcote Chief Security Officer |
|
| 3 |
An Act to control the quality, safety, efficacy and timely availability of therapeutic goods in Australia or for export and to establish a uniform approach to the safe availability and handling of poisons in Australia. Clinical trials conducted by the University using unapproved therapeutic goods (i.e. goods not approved for sale or being used for a purpose beyond the conditions of approval) must either be notified Ìýto the Therapeutic Goods Administration (TGA) under the CTN Scheme or be exempted under the CTX Scheme. |
Dr Monica Kerr Director, Ethics, Compliance & IntegrityÌý |
DSO* = Designated Specialist Officer